Prem Man Singh Chauhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Prem Man Singh Chauhan has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Moni Sharma
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, U.P., India
8 shared publicationsSuman Gupta
Division of Parasitology, CSIR-Central Drug Research Institute, Lucknow 226031, UP, India
8 shared publicationsKuldeep Chauhan
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow 226031, U.P., India
7 shared publications- Anand Kumar Pandey
A Medicinal and Process Chemistry Division , CSIR-Central Drug Research Institute , Lucknow-226031 , U.P. , India .;; Fax: +91 522 2771941 ; Tel: +522 2771940, Extn: 4659, 4660
5 shared publications Kumkum Srivastava
Division of Parasitology
5 shared publications- Rahul Shivahare
The Ohio State University Comprehensive Cancer Center, Columbus, OH
5 shared publications
Latest Publications
- 3 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Base‐Mediated Intramolecular Diels–Alder Reaction of Ugi‐Propargyl Adduct: An Efficient Route to Synthesize Highly Substituted Strained 5,9b‐Ethenobenzo[ e ]Isoindoles
The present work describes a two‐step synthesis of polycyclic 5,9b‐ethenobenzo[e]isoindoles by post‐modification of Ugi‐propargyl adducts. The procedure includes Ugi‐4CR with various aromatic/aliphatic acids, propargylamine, isocyanides, and 1‐naphthaldehyde as carbonyl components to afford Ugi‐propargyl adduct. The Ugi‐propargyl‐adduct underwent base‐mediated in situ conversion of propargyl to N ‐(allenyl)amide functionality, which concurrently led to the regioselective intramolecular Diels−Alder reaction with the naphthyl group to furnish a strained polycyclic 5,9b‐ethenobenzo[e]isoindoles adduct. Evidence for the structures relies on analytical investigations and X‐ray crystallography.
- 3 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
Base‐Mediated Intramolecular Diels–Alder Reaction of Ugi‐Propargyl Adduct: An Efficient Route to Synthesize Highly Substituted Strained 5,9b‐Ethenobenzo[ e ]Isoindoles
The present work describes a two‐step synthesis of polycyclic 5,9b‐ethenobenzo[e]isoindoles by post‐modification of Ugi‐propargyl adducts. The procedure includes Ugi‐4CR with various aromatic/aliphatic acids, propargylamine, isocyanides, and 1‐naphthaldehyde as carbonyl components to afford Ugi‐propargyl adduct. The Ugi‐propargyl‐adduct underwent base‐mediated in situ conversion of propargyl to N ‐(allenyl)amide functionality, which concurrently led to the regioselective intramolecular Diels−Alder reaction with the naphthyl group to furnish a strained polycyclic 5,9b‐ethenobenzo[e]isoindoles adduct. Evidence for the structures relies on analytical investigations and X‐ray crystallography.
- 8 February 2021
- Published by Wiley in ChemistrySelect
- Vol. 6 (6) , 1216-1222
PPh 3 Catalyzed Post‐Transformation Ugi‐4CR Intramolecular Cyclization Reaction: One‐Pot Synthesis of Functionalized Spiropyrrolidinochromanones
Stereoselective post‐transformation of Ugi ‐4CR approach leading to synthesis of functionalized spiropyrrolidinochromanones via PPh 3 catalysed intramolecular cyclization. In addition, one major finding was that, the solvent play the role of nucleophile, thus providing a highly atom economical and environmentally benign approach towards the synthesis of spiropyrrolidinochromanones.
- 8 February 2021
- Published by Wiley in ChemistrySelect
- Vol. 6 (6) , 1216-1222
PPh 3 Catalyzed Post‐Transformation Ugi‐4CR Intramolecular Cyclization Reaction: One‐Pot Synthesis of Functionalized Spiropyrrolidinochromanones
Stereoselective post‐transformation of Ugi ‐4CR approach leading to synthesis of functionalized spiropyrrolidinochromanones via PPh 3 catalysed intramolecular cyclization. In addition, one major finding was that, the solvent play the role of nucleophile, thus providing a highly atom economical and environmentally benign approach towards the synthesis of spiropyrrolidinochromanones.
- 12 June 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (22) , 6780-6785
Copper‐Mediated Intramolecular Oxidative α‐Functionalization of Ugi Precursor: An Efficient Synthesis of Highly Functionalized 2H‐Benzo[e][1,3]oxazin‐4(3H)‐one Derivatives
A novel and efficient procedure for the synthesis of highly substituted 2H‐benzo[e][1,3]oxazin‐4(3H)‐one is reported. The strategy utilizes Ugi four‐component reaction (Ugi‐4CR) methodology to afford Ugi adduct having free hydroxyl (‐OH) functional group followed by Cu/base mediated regioselective intramolecular dehydrogenative (sp 3 ) C−O bond coupling. The prepared scaffolds are found in a number of pharmaceutically relevant scaffolds such as DRF‐2519 and CX‐614 which is potential in discovery of treatment for Parkinson's disease and Alzheimer's disease respectively.
- 12 June 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (22) , 6780-6785
Copper‐Mediated Intramolecular Oxidative α‐Functionalization of Ugi Precursor: An Efficient Synthesis of Highly Functionalized 2H‐Benzo[e][1,3]oxazin‐4(3H)‐one Derivatives
A novel and efficient procedure for the synthesis of highly substituted 2H‐benzo[e][1,3]oxazin‐4(3H)‐one is reported. The strategy utilizes Ugi four‐component reaction (Ugi‐4CR) methodology to afford Ugi adduct having free hydroxyl (‐OH) functional group followed by Cu/base mediated regioselective intramolecular dehydrogenative (sp 3 ) C−O bond coupling. The prepared scaffolds are found in a number of pharmaceutically relevant scaffolds such as DRF‐2519 and CX‐614 which is potential in discovery of treatment for Parkinson's disease and Alzheimer's disease respectively.
- 12 June 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (7) , 1213-1225
Discovery of a tetrazolyl β-carboline within vitroandin vivoosteoprotective activity under estrogen-deficient conditions
β-Carbolines have been assessed for osteoclastogenesis. However, their effect on osteoblasts during estrogen deficiency is still unclear. Here, a series of novel piperazine and tetrazole tag β-carbolines have been synthesized and examined for osteoblast differentiation in vitro. In vitro data suggest that compound 8g is the most promising osteoblast differentiating agent that was evaluated for in vivo studies. Compound 8g promoted osteoblast mineralization, stimulated Runx2, BMP-2 and OCN expression levels, increased BrdU incorporation and inhibited generation of free radicals as well as nitric oxide. Since a piperazine group is involved in bone repair activity and β-carboline in IκB kinase (IKK) inhibition, compound 8g inhibited tumor necrosis factor α (TNFα) directed IκBα phosphorylation, preventing nuclear translocation of NF-κB thereby alleviating osteoblast apoptosis. In vivo studies show that compound 8g was able to restore estrogen deficiency-induced bone loss in ovariectomized rats without any toxicity, thus signifying its potential in bone-protection chemotherapy under postmenopausal conditions.
- 12 June 2018
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (7) , 1213-1225
Discovery of a tetrazolyl β-carboline within vitroandin vivoosteoprotective activity under estrogen-deficient conditions
β-Carbolines have been assessed for osteoclastogenesis. However, their effect on osteoblasts during estrogen deficiency is still unclear. Here, a series of novel piperazine and tetrazole tag β-carbolines have been synthesized and examined for osteoblast differentiation in vitro. In vitro data suggest that compound 8g is the most promising osteoblast differentiating agent that was evaluated for in vivo studies. Compound 8g promoted osteoblast mineralization, stimulated Runx2, BMP-2 and OCN expression levels, increased BrdU incorporation and inhibited generation of free radicals as well as nitric oxide. Since a piperazine group is involved in bone repair activity and β-carboline in IκB kinase (IKK) inhibition, compound 8g inhibited tumor necrosis factor α (TNFα) directed IκBα phosphorylation, preventing nuclear translocation of NF-κB thereby alleviating osteoblast apoptosis. In vivo studies show that compound 8g was able to restore estrogen deficiency-induced bone loss in ovariectomized rats without any toxicity, thus signifying its potential in bone-protection chemotherapy under postmenopausal conditions.
- 1 October 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (20) , 4643-4646
gem-Dithioacetylated indole derivatives as novel antileishmanial agents
- 1 October 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (20) , 4643-4646
gem-Dithioacetylated indole derivatives as novel antileishmanial agents
- 21 July 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (9) , 1824-1834
An insight into tetrahydro-β-carboline–tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents
A series of 2,3,4,9-tetrahydro-β-carboline tetrazole derivatives (14a–u) have been synthesized utilizing the Ugi multicomponent reaction and were identified as potential antileishmanial chemotypes. Most of the screened derivatives exhibited significant in vitro activity against the promastigote (IC50 from 0.59 ± 0.35 to 31 ± 1.27 μM) and intracellular amastigote forms (IC50 from 1.57 ± 0.12 to 17.6 ± 0.2 μM) of L. donovani, and their activity is comparable with standard drugs miltefosine and sodium stibogluconate. The most active compound 14t was further studied in vivo against the L. donovani/golden hamster model at a dose of 50 mg kg−1 through the intraperitoneal route for 5 consecutive days, which displayed 75.04 ± 7.28% inhibition of splenic parasite burden. Pharmacokinetics of compound 14t was studied in the golden Syrian hamster, and following a 50 mg kg−1 oral dose, the compound was detected in hamster serum for up to 24 h. It exhibited a large volume of distribution (651.8 L kg−1), high clearance (43.2 L h−1 kg−1) and long mean residence time (10 h).
- 21 July 2017
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (9) , 1824-1834
An insight into tetrahydro-β-carboline–tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents
A series of 2,3,4,9-tetrahydro-β-carboline tetrazole derivatives (14a–u) have been synthesized utilizing the Ugi multicomponent reaction and were identified as potential antileishmanial chemotypes. Most of the screened derivatives exhibited significant in vitro activity against the promastigote (IC50 from 0.59 ± 0.35 to 31 ± 1.27 μM) and intracellular amastigote forms (IC50 from 1.57 ± 0.12 to 17.6 ± 0.2 μM) of L. donovani, and their activity is comparable with standard drugs miltefosine and sodium stibogluconate. The most active compound 14t was further studied in vivo against the L. donovani/golden hamster model at a dose of 50 mg kg−1 through the intraperitoneal route for 5 consecutive days, which displayed 75.04 ± 7.28% inhibition of splenic parasite burden. Pharmacokinetics of compound 14t was studied in the golden Syrian hamster, and following a 50 mg kg−1 oral dose, the compound was detected in hamster serum for up to 24 h. It exhibited a large volume of distribution (651.8 L kg−1), high clearance (43.2 L h−1 kg−1) and long mean residence time (10 h).
- 1 March 2016
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 110, 237-245
Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes
- 1 March 2016
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 110, 237-245
Identification of a diverse indole-2-carboxamides as a potent antileishmanial chemotypes
- 3 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (25) , 21165-21186
Diversity oriented synthesis of β-carbolinone and indolo-pyrazinone analogues based on an Ugi four component reaction and subsequent cyclisation of the resulting indole intermediate
A one-pot domino multicomponent reaction for the rapid, integrated and versatile synthesis of highly functionalized β-carbolinones (9a–9ab) and indolo-pyrazinones (10a–10ab) has been established. The reaction involves an Ugi-four component reaction of indole 2-carboxylic acid (1 or 16a–c), aryl or alkyl aldehyde (6a–p), isocyanide (3a–e), and aminoacetaldehyde dimethyl acetal (7) followed by in situ acid-mediated deprotection/activation/electrophilic cyclisation/and aromatisation. The products were obtained from Ugi adducts in good to excellent yield within short periods of 20–30 min at room temperature (35 °C). The potential of the methodology is proved by development of a diverse library of heterocyclic compounds with point and skeletal diversity. Moreover, the synthesis has also been accomplished using N-substituted derivatives of indole 2-carboxylic acid that delivers highly diverse N-substituted β-carbolinone (18a–l) heterocycles of medicinal importance.
- 3 February 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (25) , 21165-21186
Diversity oriented synthesis of β-carbolinone and indolo-pyrazinone analogues based on an Ugi four component reaction and subsequent cyclisation of the resulting indole intermediate
A one-pot domino multicomponent reaction for the rapid, integrated and versatile synthesis of highly functionalized β-carbolinones (9a–9ab) and indolo-pyrazinones (10a–10ab) has been established. The reaction involves an Ugi-four component reaction of indole 2-carboxylic acid (1 or 16a–c), aryl or alkyl aldehyde (6a–p), isocyanide (3a–e), and aminoacetaldehyde dimethyl acetal (7) followed by in situ acid-mediated deprotection/activation/electrophilic cyclisation/and aromatisation. The products were obtained from Ugi adducts in good to excellent yield within short periods of 20–30 min at room temperature (35 °C). The potential of the methodology is proved by development of a diverse library of heterocyclic compounds with point and skeletal diversity. Moreover, the synthesis has also been accomplished using N-substituted derivatives of indole 2-carboxylic acid that delivers highly diverse N-substituted β-carbolinone (18a–l) heterocycles of medicinal importance.
- 17 November 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (124) , 102713-102722
Diversity-oriented reconstruction of primitive diketopiperazine-fused tetrahydro-β-carboline ring systems via Pictet–Spengler/Ugi-4CR/deprotection-cyclization reactions
An expedient construction of tetrahydro-β-carbolinediketopiperazine ring systems, which are present in various indole alkaloids, is documented. The synthetic strategy proceeds through a Pictet–Spengler reaction followed by an Ugi-4CR and deprotection-cyclization reactions. This is the first report of a Pre-Ugi multicomponent reaction modification using 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylic acid as the acidic partner. This novel approach provides highly diverse reconstructions of novel tetrahydro-β-carbolinediketopiperazine derivatives, which can also be used as privileged structures in medicinal chemistry.
- 17 November 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (124) , 102713-102722
Diversity-oriented reconstruction of primitive diketopiperazine-fused tetrahydro-β-carboline ring systems via Pictet–Spengler/Ugi-4CR/deprotection-cyclization reactions
An expedient construction of tetrahydro-β-carbolinediketopiperazine ring systems, which are present in various indole alkaloids, is documented. The synthetic strategy proceeds through a Pictet–Spengler reaction followed by an Ugi-4CR and deprotection-cyclization reactions. This is the first report of a Pre-Ugi multicomponent reaction modification using 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylic acid as the acidic partner. This novel approach provides highly diverse reconstructions of novel tetrahydro-β-carbolinediketopiperazine derivatives, which can also be used as privileged structures in medicinal chemistry.
- 4 November 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (2) , 351-356
Novel β-carboline–quinazolinone hybrid as an inhibitor of Leishmania donovani trypanothione reductase: Synthesis, molecular docking and bioevaluation
Trypanothione reductase (TR) is a vital enzyme in the trypanothione based redox metabolism of trypanosomatid parasites. It is one of the few chemically validated targets for Leishmania. Herein, we report the synthesis of novel β-carboline–quinazolinone hybrids that are able to inhibit Leishmania donovani TR (LdTR) and subsequently inhibit cell growth. A molecular modeling approach based on docking studies and subsequent binding free energy estimation was performed in the active site of LdTR to understand their possible binding sites. With the enzymatic assay on LdTR with compounds, we were able to identify six hit compounds (8j–8o) that were all found to be the competitive inhibitors of TR with Ki in the range of 0.8–9.2 μM. The whole-cell screening assay highlighted the analogues 8k, 8l and 8n as the most active compounds with IC50 of 4.4, 6.0 and 4.3 μM, respectively, along with an adequate selectivity index (SI) of >91, 36 and 24, respectively.
- 4 November 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (2) , 351-356
Novel β-carboline–quinazolinone hybrid as an inhibitor of Leishmania donovani trypanothione reductase: Synthesis, molecular docking and bioevaluation
Trypanothione reductase (TR) is a vital enzyme in the trypanothione based redox metabolism of trypanosomatid parasites. It is one of the few chemically validated targets for Leishmania. Herein, we report the synthesis of novel β-carboline–quinazolinone hybrids that are able to inhibit Leishmania donovani TR (LdTR) and subsequently inhibit cell growth. A molecular modeling approach based on docking studies and subsequent binding free energy estimation was performed in the active site of LdTR to understand their possible binding sites. With the enzymatic assay on LdTR with compounds, we were able to identify six hit compounds (8j–8o) that were all found to be the competitive inhibitors of TR with Ki in the range of 0.8–9.2 μM. The whole-cell screening assay highlighted the analogues 8k, 8l and 8n as the most active compounds with IC50 of 4.4, 6.0 and 4.3 μM, respectively, along with an adequate selectivity index (SI) of >91, 36 and 24, respectively.